Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02891811
What this trial is testing

Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy

Who this might be right for
Multiple Myeloma
Arbeitsgemeinschaft medikamentoese Tumortherapie 124
Not applicableLooking for participantsNCT06976164
What this trial is testing

Reflexo Therapy for Gestational Diabetes Mellitus

Who this might be right for
Physical Therapy
Kafrelsheikh University 36
Testing effectiveness (Phase 2)UnknownNCT04357106
What this trial is testing

COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma

Who this might be right for
COVID-19
Centro de Hematología y Medicina Interna 10
Not applicableNo Longer AvailableNCT05503550
What this trial is testing

Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Study completedNCT01313897
What this trial is testing

UARK 2010-35, A Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 10
Not applicableEnded earlyNCT00608517
What this trial is testing

Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)UnknownNCT01002703
What this trial is testing

Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Leipzig 50
Not applicableLooking for participantsNCT07697924
What this trial is testing

CURENDO (Cord-blood Uterine Regeneration Endometrium): Platelet-rich Plasma Therapy Derived From Umbilical Cord Blood for the Treatment of Endometrial Pathologies (Asherman Syndrome / Endometrial Atrophy / Thin Endometrium)

Who this might be right for
Asherman Syndrome
Fundación IVI 35
Testing effectiveness (Phase 2)Study completedNCT00044018
What this trial is testing

CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 102
Early research (Phase 1)UnknownNCT04295018
What this trial is testing

BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

Who this might be right for
Multiple Myeloma
Peking Union Medical College Hospital 10
Not applicableUnknownNCT05328674
What this trial is testing

Clinical and Comparative Evaluation of the Treatment Results of Arthroscopic Reconstruction of Cartilage Defects in the Knee Joint With the Use of Autogenous Cartilage Graft With PRP GF (Platelet-rich Plasma With Growth Factors)

Who this might be right for
Cartilage DamageCartilage InjuryKnee Injuries
eMKa MED Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT03548207
What this trial is testing

JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 126
Large-scale testing (Phase 3)Active Not RecruitingNCT04181827
What this trial is testing

A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 419
Testing effectiveness (Phase 2)Looking for participantsNCT06503107
What this trial is testing

Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM

Who this might be right for
Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05231629
What this trial is testing

Sequential Therapy in Multiple Myeloma Guided by MRD Assessments

Who this might be right for
Multiple Myeloma
University of Alabama at Birmingham 300
Early research (Phase 1)Study completedNCT00646139
What this trial is testing

KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment

Who this might be right for
LymphomaLymphoproliferative DisorderSmall Intestine Cancer+1 more
Roswell Park Cancer Institute 7
Not applicableLooking for participantsNCT07010900
What this trial is testing

Platelet-Rich Plasma Injections From Cord Blood + Penile Traction vs. Penile Traction Alone in Patients With Peyronie's Disease. Open-label, Single-center Randomized Study

Who this might be right for
Peyronie DiseasePenile CurvaturePRP Injection+3 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 42
Not applicableStudy completedNCT03857334
What this trial is testing

Efficacy of Platelet Rich Plasma in Plantar Fasciitis

Who this might be right for
Plantar Fascitis
University Hospital, Montpellier 50
Not applicableStudy completedNCT06869200
What this trial is testing

Study on the Use of a Concentrated Growth Factor Preparation Kit for the Treatment of Knee Osteoarthritis

Who this might be right for
Knee Osteoarthritis
Guangdong Hongzhi Health Technology 104
Not applicableStudy completedNCT07681544
What this trial is testing

Empirical Meropenem Dosing in Critically Ill Patients: Early Assessment of Plasma Exposure and Minimum Inhibitory Concentration Targets

Who this might be right for
Empirical Antimicrobial TherapyCritically IllMeropenem+1 more
Hospital Italiano de Buenos Aires 26
Next Page